Anna Bárbara de Freitas Carneiro-Proietti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Anna Bárbara de Freitas Carneiro-Proietti has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Ester C. Sabino
Pró-Sangue Foundation
2 shared publicationsFernando A. Proietti
Federal University of Minas Gerais
2 shared publicationsJúnia G. M. Cioffi
Fundação Hemominas, Belo Horizonte
2 shared publicationsBrian Custer
From the Hemominas Foundation, the Pró‐Sangue Foundation, and the Hemope Foundation, Federal University of Minas Gerais, Belo Horizonte, Brazil; Federal University of São João Del Rei, São João Del Rei, Brazil; University of São Paulo, São Paulo, Brazil; the Blood Systems Research Institute, San Francisco, CA; and Westat, Rockville, Maryland
1 shared publicationCláudia D.L. Oliveira
From the Hemominas Foundation, the Pró‐Sangue Foundation, and the Hemope Foundation, Federal University of Minas Gerais, Belo Horizonte, Brazil; Federal University of São João Del Rei, São João Del Rei, Brazil; University of São Paulo, São Paulo, Brazil; the Blood Systems Research Institute, San Francisco, CA; and Westat, Rockville, Maryland
1 shared publicationCláudia Di Lorenzo Oliveira
Federal University of São João del Rei
1 shared publication
Latest Publications
- 1 October 2012
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 28 (10) , 1265-1272
Human T-Lymphotropic Virus Type 1 and Type 2 Seroprevalence, Incidence, and Residual Transfusion Risk Among Blood Donors in Brazil During 2007–2009
Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative donor prevalence and incidence data are lacking. All blood donations (2007–2009) from three blood centers in Brazil were studied. Samples reactive on one HTLV screening test (EIA) were retested with a different EIA; dual EIA reactivity correlated strongly with a confirmatory Western blot. Prevalence, incidence, and residual transfusion risk were calculated. Among 281,760 first-time donors, 363 were positive for HTLV on both EIAs (135 per 10 5 , 95% CI 122–150). Prevalence differed considerably by region, from 83 to 222 per 10 5 . Overall incidence rate was 3.6/10 5 person-years and residual transfusion risk was 5.0/10 6 per blood unit transfused. The logistic regression model showed significant associations with: age [adjusted odds ratio (aOR)=5.23 for age 50+ vs. <20], female sex (aOR=1.97), black (aOR=2.70 vs. white), and mixed skin colors (aOR=1.78 vs. white), and inversely with education (aOR=0.49, college vs. less than high school). HTLV testing with a dual-EIA strategy is feasible and can be useful in areas with low resources. Incidence and residual risk of HTLV-1 transmission by transfusion were relatively high and could be reduced by improving donor recruitment and selection in high prevalence areas. Blood center data may contribute to surveillance for HTLV infection.
- 1 October 2012
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 28 (10) , 1265-1272
Human T-Lymphotropic Virus Type 1 and Type 2 Seroprevalence, Incidence, and Residual Transfusion Risk Among Blood Donors in Brazil During 2007–2009
Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative donor prevalence and incidence data are lacking. All blood donations (2007–2009) from three blood centers in Brazil were studied. Samples reactive on one HTLV screening test (EIA) were retested with a different EIA; dual EIA reactivity correlated strongly with a confirmatory Western blot. Prevalence, incidence, and residual transfusion risk were calculated. Among 281,760 first-time donors, 363 were positive for HTLV on both EIAs (135 per 10 5 , 95% CI 122–150). Prevalence differed considerably by region, from 83 to 222 per 10 5 . Overall incidence rate was 3.6/10 5 person-years and residual transfusion risk was 5.0/10 6 per blood unit transfused. The logistic regression model showed significant associations with: age [adjusted odds ratio (aOR)=5.23 for age 50+ vs. <20], female sex (aOR=1.97), black (aOR=2.70 vs. white), and mixed skin colors (aOR=1.78 vs. white), and inversely with education (aOR=0.49, college vs. less than high school). HTLV testing with a dual-EIA strategy is feasible and can be useful in areas with low resources. Incidence and residual risk of HTLV-1 transmission by transfusion were relatively high and could be reduced by improving donor recruitment and selection in high prevalence areas. Blood center data may contribute to surveillance for HTLV infection.
- Open Access
- 1 December 2010
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 43 (6) , 615-619
Decline in prevalence and asymmetric distribution of human T cell lymphotropic virus 1 and 2 in blood donors, State of Minas Gerais, Brazil, 1993 to 2007
INTRODUCTION: Human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) are endemic in Brazil and are screened for in transfusion services since 1993. This study evaluated the evolution of the prevalence of HTLV-1 and 2 in blood donors of the Hemominas Foundation from 1993 to 2007, and its geographical distribution in State of Minas Gerais, Brazil. METHODS: The Hemominas Foundation is a centralized blood center in Minas Gerais, Brazil. The sources of data were the Hemominas Foundation Technical Bulletin and files from the centralized serological laboratory. Donors were tested in the period using enzyme linked immuno sorbent assays (ELISA), followed by Western blot, when repeatedly reactive. The data were analyzed by EPIINFO 6.2 and TABWIN 3.5 softwares. RESULTS: The average seroprevalence in the period 1993-2007 was 0.1%. A steady decline occurred from 0.4% in 1993 to below 0.1% in 2002 and later, with a transient peak of 0.5% in 1994. HTLV reactivity distribution was asymmetrical in the state, with regions of higher prevalence, interspersed with low prevalence areas. Comparison of positive and negative donors verified that increasing age was proportional to virus positivity. Odds ratio for age ranged from 1.43 (30 to 39 years-old) to 3.09 (50 to 65 years-old). Women had a greater chance of being positive (OR-1.64), as previously described. CONCLUSIONS: Possible explanations for HTLV-1/2 prevalence decline are the exclusion of positive donors from the donor pool, an increase in repeat donors and ELISA test improvement, with reduction in the number of false positive results.
- 1 December 2010
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 43 (6) , 615-619
Open AccessDecline in prevalence and asymmetric distribution of human T cell lymphotropic virus 1 and 2 in blood donors, State of Minas Gerais, Brazil, 1993 to 2007
INTRODUCTION: Human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) are endemic in Brazil and are screened for in transfusion services since 1993. This study evaluated the evolution of the prevalence of HTLV-1 and 2 in blood donors of the Hemominas Foundation from 1993 to 2007, and its geographical distribution in State of Minas Gerais, Brazil. METHODS: The Hemominas Foundation is a centralized blood center in Minas Gerais, Brazil. The sources of data were the Hemominas Foundation Technical Bulletin and files from the centralized serological laboratory. Donors were tested in the period using enzyme linked immuno sorbent assays (ELISA), followed by Western blot, when repeatedly reactive. The data were analyzed by EPIINFO 6.2 and TABWIN 3.5 softwares. RESULTS: The average seroprevalence in the period 1993-2007 was 0.1%. A steady decline occurred from 0.4% in 1993 to below 0.1% in 2002 and later, with a transient peak of 0.5% in 1994. HTLV reactivity distribution was asymmetrical in the state, with regions of higher prevalence, interspersed with low prevalence areas. Comparison of positive and negative donors verified that increasing age was proportional to virus positivity. Odds ratio for age ranged from 1.43 (30 to 39 years-old) to 3.09 (50 to 65 years-old). Women had a greater chance of being positive (OR-1.64), as previously described. CONCLUSIONS: Possible explanations for HTLV-1/2 prevalence decline are the exclusion of positive donors from the donor pool, an increase in repeat donors and ELISA test improvement, with reduction in the number of false positive results.
- 25 March 2010
- Published by Wiley in Transfusion
- Vol. 50 (4) , 918-925
Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008
- 25 March 2010
- Published by Wiley in Transfusion
- Vol. 50 (4) , 918-925
Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008
- Open Access
- 1 August 2009
- Published by Elsevier in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 31 (4) , 217-218
Controle e produção de hemoderivados indústria nacional e inovação
- 1 August 2009
- Published by Elsevier in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 31 (4) , 217-218
Open AccessControle e produção de hemoderivados indústria nacional e inovação
- Open Access
- 1 January 2008
- Published by Elsevier in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 30 (3) , 173-174
Hemovigilância: verificação final da qualidade da transfusão?
- 1 January 2008
- Published by Elsevier in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 30 (3) , 173-174
Open AccessHemovigilância: verificação final da qualidade da transfusão?